Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry.

@article{Meliga2013CoronaryAB,
  title={Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry.},
  author={Emanuele Meliga and Mauro de Benedictis and Alaide Chieffo and Azeem Latib and Seung Jung Park and Young Hak Kim and Yoshinobu Onuma and Piera Capranzano and Sanda Jēgere and Raj Makkar and I. de. Frutos Palacios and Pawel E Buszman and Marta Bande and Tarun Chakravarty and Roxana Mehran and Christoph Naber and Innocenzo Scrocca and Ronan Margey and Martin Leon and Jeffrey Moses and Jean Fajadet and Thierry Lefevre and Marie Claude Morice and Andrejs Ērglis and Corrado Tamburino and Ottavio Alfieri and Maria Rosa Conte and Patrick W Serruys and Antonio Colombo},
  journal={EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
  year={2013},
  volume={9 7},
  pages={
          803-8
        }
}
AIMS Data regarding the impact on clinical outcomes of PCI with DES implantation vs. CABG to treat unprotected left main coronary artery (ULMCA) disease in diabetic patients are still insufficient. The present study evaluated the short-term and long-term results of percutaneous and surgical revascularisation in diabetic patients with ULMCA disease in a large population. METHODS AND RESULTS A total of 826 diabetic patients with ULMCA stenosis who received DES (n=520) or underwent CABG (n=306… CONTINUE READING
BETA